dc.creator | Ortíz Ramírez, Mario | |
dc.date.accessioned | 2013-11-12T18:53:37Z | |
dc.date.accessioned | 2023-07-19T14:05:48Z | |
dc.date.available | 2013-11-12T18:53:37Z | |
dc.date.available | 2023-07-19T14:05:48Z | |
dc.date.created | 2013-11-12T18:53:37Z | |
dc.date.issued | 2011 | |
dc.identifier | http://repository.uaeh.edu.mx/bitstream/handle/123456789/13984 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/7705198 | |
dc.description.abstract | Pharmacovigilance is defined as watchfulness in guarding against danger from drugs or providing for safety of
drugs. It can also be a dedicated department whose role is to monitor toxicity and safety of drugs both in the
developmental phase and post marketing. A working group on Pharmacovigilance aims to develop workable
operating procedures for the publicly funded research community for reporting, monitoring and managing
adverse reactions and events that will satisfy the requirements
of the Medicines for Human Use (Clinical
Trials) Regulations. It is also envisaged that the group will review and evaluate information from healthcare
providers and patients on the adverse effects of medications, biological products, herbalism and traditional
medicines. | |
dc.language | en | |
dc.subject | Research Subject Categories::MEDICINE | |
dc.title | Pharmacovigilance of Psychoactive Medications in a Mexican Psychiatric Hospital | |
dc.type | Presentation | |